FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2025, on Monday, November 3, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, November 4, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, Pres. ...

Core Insights - The Zacks Medical - Outpatient and Home Healthcare industry is experiencing a significant shift towards digital healthcare, driven by rising demand for telemedicine and AI-powered services, particularly due to an aging global population and increasing healthcare costs [1][4][10] Industry Overview - The industry includes companies providing outpatient care using advanced medical technologies for diagnosis, treatment, and rehabilitation, with a focus on innovation and value-based care models [3] - The global home healthcare market was valued at $416.4 billion in 2024 and is projected to reach $747.70 billion by 2030, growing at a CAGR of approximately 10.2% [1] Major Trends - Aging Population: The growing elderly population is a primary driver for home healthcare services, as older individuals prefer receiving care in familiar home settings [4] - Cost Effectiveness: Outpatient clinics offer cost-effective care, reducing the financial burden on patients and healthcare systems [5] - AI's Role: AI enhances patient care through remote monitoring and data analysis, facilitating timely interventions and improving care management [7] - Technological Advancements: Virtual assistants and chatbots are increasingly used to assist patients in managing their care and appointments [8] Staffing Challenges - The U.S. healthcare industry faces severe staffing shortages, particularly among home health aides, exacerbated by high burnout rates and international migration of health workers [11] Market Performance - The industry has underperformed compared to the S&P 500, losing 0.5% over the past year, while the S&P 500 rose by 18.2% [14] - The industry's current valuation is at a forward P/E of 19.6X, compared to the S&P 500's 23.4X [18] Company Highlights - **Quest Diagnostics**: Anticipates 2025 revenue growth of 9.9% and earnings growth of 9.1%, with a current ROE of 15.2% [21][22][25] - **DaVita**: Expected revenue growth of 5% and earnings growth of 12.9% for 2025, with an impressive ROE of 369.4% [26][27][30] - **Addus HomeCare**: Forecasts a 21.5% increase in revenues and a 16.5% rise in earnings for 2025, with a ROE of 9.4% [31][32][34] - **The Pennant Group**: Projects a 26.5% growth in revenues and a 21.3% increase in earnings for 2025, with a ROE of 9.9% [35][36][37]

Core Viewpoint - Addus HomeCare Corporation will participate in the Jefferies 2025 Healthcare Services Conference, indicating its engagement with industry stakeholders and potential for future growth [1] Company Participation - Dirk Allison, Chairman and CEO, and Brian Poff, Executive Vice President and CFO, will represent the company at the conference [1] - The event is scheduled for September 29 - 30, 2025, in Nashville, Tennessee [1] Presentation Details - There will be a live broadcast and replay of the company's presentation during the conference [1]

Core Insights - Nova Leap Health Corp. has completed the acquisition of a home care services company in Nova Scotia for a total consideration of CAD 390,000, fully paid at closing [2] - The Target company reported unaudited revenues of approximately CAD 1.1 million and adjusted EBITDA of approximately CAD 95,000 for the fiscal year 2024 [1] - Nova Leap is focused on expanding its market presence in Nova Scotia and operates in one of the fastest-growing industries in the U.S. and Canada, particularly in dementia care [2] Company Overview - Nova Leap is recognized for its growth, achieving rankings such as 42 and 2 on the 2021 and 2020 Report on Business ranking of Canada's Top Growing Companies, and 10 in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector [2] - The company operates in eight different U.S. states and Nova Scotia, indicating a geographically diversified business model [2]